Impact of type 2 biomarkers on changes in subjective cough outcomes in chronic coughEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
A comparative analyses of group 2 innate lymphoid cells in sputum from patients with non- asthmatic eosinophilic bronchitis and allergic asthmaEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Patient perception on the effectiveness of guideline-based treatment for chronic coughEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Frequency of cough triggers associated with worse quality of life in patients with chronic coughEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Higher inflammatory eosinophil levels in eosinophilic bronchitis compared to mild allergic asthmaEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Relationship between subjective cough outcomes and activity impairment in patients with chronic coughEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Demographics and subjective cough outcomes of guideline-based treatment in the McMaster Cough Clinic.EUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Work productivity and activity impairment among chronic cough patients after a guideline-based treatment in the McMaster Cough ClinicEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Surface receptor expression on circulating and airway eosinophils after inhaled allergen challengeEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Relationship between measures of type II inflammation and patient reported cough severity and quality of life outcomes in patients with chronic coughEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Blocking Focal adhesion kinase (FAK) protects against damage in a novel model of lymphocyte dominant lung injuryEUROPEAN RESPIRATORY JOURNALIF212020-10-281PRE